Gastroesophageal and bile reflux after one-anastomosis gastric bypass: long-term outcomes in a functionally evaluated cohort
Abstract
BACKGROUND
One-anastomosis gastric bypass (OAGB) is increasingly performed worldwide, but concerns persist regarding postoperative gastroesophageal reflux disease (GERD), bile reflux, and related complications.
OBJECTIVES
To evaluate the incidence and clinical relevance of GERD and bile reflux after OAGB and to investigate whether preoperative esophageal functional parameters predict postoperative reflux-related complications.
SETTING
Department of General Surgery, Policlinico San Marco, Bergamo, Italy.
METHODS
This retrospective cohort study included 150 consecutive patients undergoing laparoscopic OAGB between 2016 and 2023. All patients underwent preoperative esophagogastroduodenoscopy and esophageal manometry, with selective pH-impedance monitoring when indicated. Postoperative GERD, esophagitis, bile reflux, anastomotic ulcers, and revisional surgery were assessed during a follow-up of 24-84 months. At last follow-up, 142 patients were available for evaluation, while 8 patients (5.3%) were lost to follow-up.
RESULTS
The mean preoperative body mass index was 48 kg/m2, decreasing to 27 kg/m2 at last follow-up. Postoperative GERD developed in 26 patients (17.3%), all of whom had a preoperative hypotensive lower esophageal sphincter (LES) (<16 mmHg). Bile reflux was diagnosed in 30 patients (20%) by pH-impedance monitoring and was refractory to medical therapy in all cases, leading to conversion to Roux-en-Y gastric bypass (RYGB) with complete symptom resolution.…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 150 participants or records.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.